Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 9—September 2021
Dispatch

Ongoing High Incidence and Case-Fatality Rates for Invasive Listeriosis, Germany, 2010–2019

Hendrik WilkingComments to Author , Raskit Lachmann, Alexandra Holzer, Sven Halbedel, Antje Flieger, and Klaus Stark
Author affiliations: Department for Infectious Disease Epidemiology of the Robert Koch Institute, Berlin, Germany (H. Wilking, R. Lachmann, A. Holzer, K. Stark); Department for Infectious Diseases of the Robert Koch Institute, Wernigerode, Germany (S. Halbedel, A. Flieger)

Cite This Article

Abstract

We used 10 years of surveillance data to describe listeriosis frequency in Germany. Altogether, 5,576 cases were reported, 91% not pregnancy associated; case counts increased over time. Case-fatality rate was 13% in non–pregnancy-associated cases, most in adults ≥65 years of age. Detecting, investigating, and ending outbreaks might have the greatest effect on incidence

Listeria monocytogenes infections are primarily foodborne and cause gastrointestinal disease or invasive syndromes among infected persons (1). Because L. monocytogenes is an intracellular pathogen and because invasive listeriosis is the primary manifestation in diagnosed listeriosis, persons with deficient cell-mediated immunity are at increased risk for its symptoms, including sepsis and meningitis. In addition, infection during pregnancy can lead to chorioamnionitis and fetal infection that can result in miscarriage and stillbirth even 2 months after the mother is exposed. One study found that 44% of patients with non–pregnancy-associated (NPA) listeriosis in Germany had received immunosuppressive therapy ≤3 months before illness onset and another 28% had a coexistent immunocompromising illness, such as diabetes (2). Testing for bacteria in blood cultures or cerebrospinal fluid (CSF) is recommended for diagnosis.

Listeria is ubiquitous in the environment and can produce biofilms in the food production environment and thus contaminate ready-to-eat (RTE) products, which are typically consumed raw or without further processing. Listeria species grow during shelf life, even at low temperatures, and multiply to concentration levels that make invasive listeriosis and outbreaks more likely. For these reasons, it is suspected that L. monocytogenes exposure is very common but the disease rare. However, in recent years several large outbreaks have been reported in Germany (37).

The Study

Figure 1

Distribution of pregnancy-associated and non–pregnancy-associated listeriosis cases, by year and quarter, Germany, 2010–2019 (n = 5,576). In the x-axis labels, I corresponds to January–March, II to April–June, III to July–September, and IV to October–December. Before the third quarter of 2015, two groups of patients were not included in the reference definition: those with unknown or unfulfilled clinical criteria and those with nucleic acid detection only. Data from these groups are displayed separately to make the changes in trends over time more apparent.

Figure 1. Distribution of pregnancy-associated and non–pregnancy-associated listeriosis cases, by year and quarter, Germany, 2010–2019 (n = 5,576). In the x-axis labels, I corresponds to January–March, II to April–June, III to July–September,...

We analyzed mandatory notification data about invasive listeriosis cases in Germany during 2010–2019 to describe time trends, case-fatality rates, demographic distribution, clinical and diagnostic characteristics, and geographic trends (Appendix). In total, 5,576 listeriosis cases were reported during the 10-year study period; 5,064 (91%) of those were NPA and 486 (9%) were pregnancy associated, 241 in mothers and 245 in newborns. Information on disease manifestation was not transmitted for 26 cases. The lowest annual incidence was in 2011 (0.41/100,000 residents) and the highest in 2017 (0.93/100,000 residents); the average for 2010–2019 was 0.69/100,000 residents. We observed a steady increase in cases during 2011–2017, but incidence in 2019 was lower than in previous years. Exceptionally high numbers were reported in the third quarters of 2016, 2017, and 2018 (Figure 1).

Among the 5,064 NPA listeriosis case-patients, 2,032 (40%) were female and 3,855 (76%) were >65 years of age (Table 1). Listeriosis among adolescents and children other than newborns is rare (37 cases). Incidence in adults 18–44 years of age is <0.1/100,000 residents, in contrast with incidence among adults ≥85 years of age: 3.99/100,000 residents for men and 2.08/100,000 residents for women. Annual median age of case-patients increased steadily from 72 years of age in 2010 to 77 years of age in 2019.

Figure 2

Distribution of non–pregnancy-associated listeriosis cases (n = 5,061) in which the patients died (n = 658) and case-fatalities by year and cause of death, Germany, 2010–2019. Black line indicates percentage of infected persons who died.

Figure 2. Distribution of non–pregnancy-associated listeriosis cases (n = 5,061) in which the patients died (n = 658) and case-fatalities by year and cause of death, Germany, 2010–2019. Black line indicates percentage...

Sources for testing samples included CSF (657, 13%), blood (4,097, 81%), and material from other usually sterile sites (274, 5%) (Table 2). A significantly higher proportion of L. monocytogenes was detected in CSF among adults 18–64 years of age (24%) than among those >65 years of age (9%) (p<0.01); for most case-patients >65 years of age, the isolate was detected from blood. Most NPA case-patients (95%) were hospitalized; we found no differences among age groups (p = 0.689). Altogether, 658 NPA case-patients have been reported deceased. The case-fatality rate for NPA cases was 13%, significantly higher among patients >65 years of age (14%) than among those 18–64 years of age (10%; p<0.001). Listeriosis was the main cause of death for 324 (49%) of NPA case-patients and a contributing factor for 280 (43%). NPA case-fatality rates increased over the 10-year study period, but mainly because of an increase in listeriosis case-patients who died from causes other than listeriosis (Figure 2). For 54 (8%) deceased case-patients, cause-of-death information was missing. Of 301 pregnancy-associated cases, 50% were confirmed from blood cultures and 54% from samples of newborn, stillborn, or maternal tissues (in some cases, both). A total of 32 fetal losses and 26 neonatal deaths resulted in a case-fatality rate of 19% for pregnancy-associated cases.

Conclusions

The aging of the population of Germany as a result of demographic shifts that will continue in the coming years may partially explain the increase in listeriosis cases and the median age of patients. In addition, factors related to the foodborne nature of the disease and an increase in exposure to Listeria must be presumed; it is possible that people eat more RTE food or that RTE food is more likely to become contaminated, although only single-case findings of L. monocytogenes >100 CFU/g have been detected in RTE foods in recent years (8).

The additional case numbers in some quarters of the year (Figure 1) were all associated with large-scale outbreaks (3,6). Successfully identifying and controlling large outbreaks, especially after whole-genome sequencing–based surveillance was introduced, possibly explains why the trend in increases ended after 2017 (9). Overall listeriosis incidence in Germany is higher than in all neighboring countries except Denmark (10). In Europe, incidence is generally higher in countries in Scandinavia and the Baltic region and lower in the United Kingdom and Ireland (10).

As is the case for other pathogens, listeriosis surveillance results in underascertainment, although it is difficult to quantify by how much. Listeria sepsis cannot be clinically distinguished from other bacterial sepsis, and isolating Listeria or detecting DNA from blood samples is often impossible because bacteremia is absent or intermittent. In addition, laboratory diagnostic testing is often not performed after abortions or stillbirths or for persons who are found dead.

Listeriosis has one of the highest case-fatality rates among notifiable infectious diseases. The case-fatality rate for Germany in this study is surprisingly lower than that for Europe overall, 15.6% (10), and for the United States, 21% (11). A cohort study in France reported a 3-month death rate of 45% for bacteremia from Listeria infection and 30% for neurolisteriosis cases (12). Lower rates may be partially explained by well-equipped intensive care units, but it is more likely that many deaths occurring long after original disease notifications were not reported to public health departments.

Of interest, surveillance data from the United States indicate more listeriosis among women and higher proportions of pregnancy-associated cases (11,13) than in our study. One explanation might be that, in Germany, meat products, more often eaten by men, constitute prominent outbreak vehicles (3,4,6,7), whereas in the United States several outbreaks were caused by nonanimal products or cheese (11).

Systematic whole-genome sequence typing of Listeria isolates from patients would aid in detecting and investigating outbreaks. These molecular data should be integrated into surveillance data from cases notifications and isolates found in food. Combining data from molecular surveillance with epidemiologic investigations would help systematically identify and eliminate contaminated sources, which might have the greatest effect on reducing the overall burden of listeriosis and thus flattening its high incidence curve. Two factors interact to have the greatest influence on personal risk profiles. Listeriosis is highly associated with age, which is affirmed in our study, and strongly associated with documented immunosuppressive conditions (2). Persons with these risk profiles should be targeted in information campaigns about how to safely consume RTE foods and avoid certain types of cheeses, meat products, and smoked or graved (cured) fish products. All food producers, and especially those providing food for immunocompromised patients in healthcare facilities, should take steps to minimize L. monocytogenes hazards when producing, selecting, and preparing food.

Dr. Wilking is an epidemiologist and deputy head of the Unit for Gastrointestinal Infections, Zoonoses and Tropical Infections at Robert Koch Institute in Berlin, Germany. He has a strong interest in foodborne diseases.

Top

Acknowledgment

We thank all stakeholders in listeriosis surveillance, especially the local and federal state authorities in Germany and at the Robert Koch Institute in Berlin.

Top

References

  1. Allerberger  F, Wagner  M. Listeriosis: a resurgent foodborne infection. Clin Microbiol Infect. 2010;16:1623. DOIPubMedGoogle Scholar
  2. Preußel  K, Milde-Busch  A, Schmich  P, Wetzstein  M, Stark  K, Werber  D. Risk factors for sporadic non-pregnancy associated listeriosis in Germany—immunocompromised patients and frequently consumed ready-to-eat products. PLoS One. 2015;10:e0142986. DOIPubMedGoogle Scholar
  3. Halbedel  S, Wilking  H, Holzer  A, Kleta  S, Fischer  MA, Lüth  S, et al. Large nationwide outbreak of invasive listeriosis associated with blood sausage, Germany, 2018–2019. Emerg Infect Dis. 2020;26:145664. DOIPubMedGoogle Scholar
  4. Kleta  S, Hammerl  JA, Dieckmann  R, Malorny  B, Borowiak  M, Halbedel  S, et al. Molecular tracing to find source of protracted invasive listeriosis outbreak, southern Germany, 2012–2016. Emerg Infect Dis. 2017;23:16803. DOIPubMedGoogle Scholar
  5. Lachmann  R, Halbedel  S, Adler  M, Becker  N, Allerberger  F, Holzer  A, et al. Nationwide outbreak of invasive listeriosis associated with consumption of meat products in health care facilities, Germany, 2014-2019. Clin Microbiol Infect. 2021;27:1035.e15. DOIPubMedGoogle Scholar
  6. Lüth  S, Halbedel  S, Rosner  B, Wilking  H, Holzer  A, Roedel  A, et al. Backtracking and forward checking of human listeriosis clusters identified a multiclonal outbreak linked to Listeria monocytogenes in meat products of a single producer. Emerg Microbes Infect. 2020;9:16008. DOIPubMedGoogle Scholar
  7. Ruppitsch  W, Prager  R, Halbedel  S, Hyden  P, Pietzka  A, Huhulescu  S, et al. Ongoing outbreak of invasive listeriosis, Germany, 2012 to 2015. Euro Surveill. 2015;20:20. DOIPubMedGoogle Scholar
  8. Bundesamt für Verbraucherschutz und Lebensmittelsicherheit (BVL). Zoonoses monitoring [German]. 2020 [cited 2021 June 8]. https://www.bvl.bund.de/DE/Arbeitsbereiche/01_Lebensmittel/01_Aufgaben/02_AmtlicheLebensmittelueberwachung/06_ZoonosenMonitoring/lm_zoonosen_monitoring_node.html
  9. Halbedel  S, Prager  R, Fuchs  S, Trost  E, Werner  G, Flieger  A. Whole-genome sequencing of recent Listeria monocytogenes isolates from Germany reveals population structure and disease clusters. J Clin Microbiol. 2018;56:e0011918. DOIPubMedGoogle Scholar
  10. European Food Safety Authority and European Centre for Disease Prevention and Control. The European Union One Health 2018 zoonoses report. 2019 [cited 2021 June 8]. https://www.ecdc.europa.eu/en/publications-data/european-union-one-health-2018-zoonoses-report
  11. Centers for Disease Control and Prevention (CDC). Vital signs: Listeria illnesses, deaths, and outbreaks—United States, 2009-2011. MMWR Morb Mortal Wkly Rep. 2013;62:44852.PubMedGoogle Scholar
  12. Charlier  C, Perrodeau  É, Leclercq  A, Cazenave  B, Pilmis  B, Henry  B, et al.; MONALISA study group. Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study. Lancet Infect Dis. 2017;17:5109. DOIPubMedGoogle Scholar
  13. European Centre for Disease Prevention and Control. Listeriosis annual epidemiological report for 2017. 2020 [cited 2021 June 8]. https://www.ecdc.europa.eu/sites/default/files/documents/listeriosis-annual-epidemiological-report-2017.pdf

Top

Figures
Tables

Top

Cite This Article

DOI: 10.3201/eid2709.210068

Original Publication Date: August 09, 2021

Table of Contents – Volume 27, Number 9—September 2021

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

Hendrik Wilking, Robert Koch Institute, Seestraße 10, 13353 Berlin, Germany

Send To

10000 character(s) remaining.

Top

Page created: June 22, 2021
Page updated: August 18, 2021
Page reviewed: August 18, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external